Inactive ingredient listing should be required on outer container only, NDMA tells FDA.
This article was originally published in The Tan Sheet
Executive Summary
INACTIVE INGREDIENT PLACEMENT ON OUTER CONTAINER ONLY suggested by the Nonprescription Drug Manufacturers Association in March 31 comments to FDA. The decision to use an OTC product is "ordinarily made at the point of purchase, therefore the listing generally should be visible at that point," NDMA asserts, adding that the space on a product's inner container should be "conserved for other required labeling." The association's comments address the listing of active and inactive ingredients on OTC labels as required by the FDA Modernization Act.